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Abstract: Introduction: In recent years, procedures with the use of dental implants have increased worldwide, 
reaching approximately one million dental implants per year. In recent years, a platelet concentrate called FRP 
(fibrin-rich plasma) has been the subject of clinical studies. Associated with this, the biomaterial Bio-Oss® 
(Geistlich), as it is biodegradable, biocompatible, non-toxic, and has low immunogenicity, and bio stimulators can 
act in the regeneration of bone tissue, as it establishes with the cells the appropriate biological niche (favorable 
microenvironment) for bone growth. Objective: Therefore, the present study aimed to evaluate, through a brief 
systematic review, the results that involve bone formation for dental implantation, with the use of biomaterials 
such as fibrin-rich plasma and Bio-Oss®. Methods: The model used for the review was PRISMA. Was used 
databases such as Scopus, Scielo, Lilacs, Google Scholar, PubMed. Results: Fibrin-rich plasma (FRP) as an 
autologous biomaterial for use in oral and maxillofacial surgery presents most leukocytes, platelets, and growth 
factors, forming a fibrin matrix, with three-dimensional architecture. The Bio-Oss® biomaterial (Geistlich), as it is 
biodegradable, biocompatible, non-toxic, and has low immunogenicity and bio stimulators can act in the 
regeneration of bone tissue, since it establishes with the adenomatous mesenchymal stem cells the appropriate 
biological niche for bone growth and, thus, allowing the dental implant to be as effective as possible. Conclusion: 
The use of FRP associated with Bio-Oss® seems to illustrate high success rates with minimal costs, which may 
reduce the amount of bone graft needed to fill the sinus cavity, reducing the costs of the procedure. 
 
Keywords: Biomaterials, Bio-Oss®, Fibrin-rich plasma, Bucomaxillofacial surgery, Bone augmentation.  
 
Introduction 
In recent years, procedures with the use of 
dental implants have increased worldwide, reaching 
approximately one million dental implants per year [1]. 
In this sense, the development of biomaterials for use 
in dental clinics in recent years has represented a 
powerful therapeutic tool in the correction of bone 
defects and consequent effective action for the dental 
implant process [1,2]. 
Thus, maxillary atrophy is an increasingly 
frequent clinical condition and the causes that lead to 
focal or generalized atrophy are in multiple factors 
[3,4]. After the loss of the affected teeth, resorption is 
maximum in the first year and more pronounced in the 
anterior areas than in the posterior ones. Thus, in the 
following years there is a minimal, but constant, 
decrease in the residual bone quantity [5,6]. 
Also, bone density influences the operative 
protocol and the choice of the type of implant used to 
replace missing teeth [6]. For a graft material to 
assume the role of insufficient bone substitute, it 
meets the criteria of biocompatibility, it has an optimal 
response to biomechanical stress, and a great capacity 
to replace the functions of synthesis/remodeling of the 
bone structure [1]. 
In this scenario, the gold standard is the use 
of autologous bone from the intraoral area with the 
greatest biocompatibility, due to the same 
embryogenic derivation and the presence of bone 
morphogenetic protein (BMP) favoring osteoinduction, 
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being the perfect material for sinus elevation. [7]. Also, 
it is the only material with osteogenic properties, in 
addition to osteoinductive and osteoconductive 
properties [2,8]. 
In this context, from the second half of the 
1990s, the attention of the “Oral and Maxillofacial 
Surgery Community” was attracted by a series of 
scientific studies, which claimed that a platelet-derived 
growth factor could be valid not only for homeostasis 
but also bone graft field [9]. Thus, in recent years, a 
platelet concentrate called FRP (fibrin-rich plasma) has 
been the subject of clinical studies [10]. 
FRP belongs to a new generation of platelet 
concentrates. After the artificial and inflammatory 
hemostatic phenomenon induced by centrifugation, 
this concentrate releases different cytokines slowly and 
gradually, in addition to growth factors such as the 
vascular endothelial growth factor (VEGF). Thus, the 
FRP is then able to regulate inflammation and 
stimulate the immune process of chemotaxis [10,11]. 
Associated with this, the biomaterial Bio-Oss® 
(Geistlich), as it is biodegradable, biocompatible, non-
toxic, and has low immunogenicity, and bio stimulators 
can act in the regeneration of bone tissue, as it 
establishes with the cells the appropriate biological 
niche (favorable microenvironment) for bone growth. 
With the use of Bio-Oss®, it is possible to obtain 
orthodontic movement in patients after treatment with 
bone regeneration. Also, resorbable membranes 
proved to be superior to non-resorbable membranes in 
the generation of vertical bone filling [2]. 
Therefore, the present study aimed to 
evaluate, through a brief systematic review, the results 
that involve bone formation for dental implantation, 




Clinical studies were included (case reports, 
retrospective, prospective and randomized studies) 
with qualitative and/or quantitative analysis. Initially, 
the keywords were determined by searching the DeCS 
tool (Descriptors in Health Sciences, BIREME base) and 
then verified and validated by MeSH System (Medical 
Subject Headings, the US National Library of Medicine) 




Descriptors (MeSH Terms) 
The main descriptors (MeSH Terms) used were 
“Biomaterials”, “Bio-Oss®”, “Fibrin-rich plasma”, 
“Bucomaxillofacial surgery” and “Bone augmentation”. 
For further specifications, the description “bone 
regeneration” for refinement was added during the 
research, following the rules of the systematic review-
PRISMA (Transparent reporting of systematic reviews 
andmeta-analyzes- http://www.prisma statement.org). 
The bibliographic search was performed using 
online databases Scopus, Scielo, Lilacs, Google Scholar 
and PubMed. The deadline and related research have 
been stipulated covering all available literature on 
virtual libraries. 
 
Series of Articles and Eligibility 
102 articles were found involving implantology 
and biomaterials. Initially, duplication of articles was 
excluded. After this process, abstracts were evaluated 
and a new exclusion was performed, removing articles 
that did not contemplate bone regeneration with the 
use of Biomaterials (allogeneic bone) and plasma rich 
in fibrin. A total of 49 articles were evaluated in full 
and 29 were included and evaluated in the present 
study. 
 
Selection of studies and risk of bias in each 
study 
Two independent reviewers (1 and 2) carried 
out research and study selection. Data extraction was 
performed by reviewer 1 and completely reviewed by 
reviewer 2. A third investigator decided on some 
conflicting points and made the final decision to 
choose the articles. Only studies reported in 
Portuguese and English were evaluated. The Cochrane 
Instrument was adopted to assess the quality of the 
included studies [12]. 
 
Major Results of The Review and 
Discussion 
Risk of bias 
Considering the Cochrane tool for risk of bias, 
the overall assessment resulted in 5 studies with a 
high risk of bias and 3 studies with uncertain risk. The 
domains that presented the highest risk of bias were 
related to the number of participants in each study 
approached, and the uncertain risk was related to the 
time of bone maturation for the implantation. Also, 
there was an absence of the source of funding in 4 
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studies and 3 studies did not disclose information 
about the conflict of interest statement. 
 
Major Findings 
The maxillary sinus is the largest of the 
paranasal sinuses and has the function of contributing 
to the resonance of phonation, conditioning of the air 
we breathe, and aid in the production of mucus in the 
nasal cavity [11]. It also acts to equalize barometric 
pressures in the nasal cavity, which is covered by a 
membrane called the Schneider membrane. This 
membrane is constituted by a pseudostratified ciliated 
cylindrical epithelium with calciform cells that produces 
mucus. The importance of knowing the constitution of 
this epithelium is because these hair cells play a 
fundamental role in the physiology of the maxillary 
sinus. While the calciform cells produce mucus, these 
cilia generate movements that cause this mucus to 
move to the drainage site of the maxillary sinus. The 
maxillary sinus drains through its ostium in the nasal 
cavity, which usually happens in the middle meatus. 
Around 25% of all the maxillary sinuses, there is an 
accessory bone that is located a lower part than the 
main ostium, and all the mucus produced and the 
particles trapped in this mucus are directed through 
the ciliary beat to the ostium. [11]. 
When the loss of a dental element occurs in 
the posterior region of the maxilla, there is natural 
resorption of the alveolar process and at the same 
time, there will be pneumatization of the maxillary 
sinus. It will increase its volume towards the place 
where the roots existed and this will often make it 
difficult or impossible to restore implants in the place. 
For this reason, the procedure for lifting the maxillary 
sinus floor should be performed, or short implants 
when possible [11]. When grafting procedures are 
needed, our focus is often on the type of biomaterial 
to be used and in fact, the success and predictability of 
our results do not depend only on the biomaterial. It is 
also necessary to consider the type of defect to be 
treated, its morphology. The morphology will impact 
mainly because the defects have different 
vascularization capacity, different osteogenic cell 
recruitment capacity, different natural graft 
stabilization capacity, therefore, we must consider the 
characteristics of the biomaterial that we must use, but 
also, the characteristics of the bed and the bone defect 
that we intend to treat [11]. 
Several surgical techniques can be used to 
reconstruct the atrophic alveolar ridge, techniques 
isolated or associated with autogenous, allogeneic, 
xenogenous grafts, and alloplastic biomaterials. The 
autogenous bone graft is the only one capable of 
presenting three important biological properties 
(osteogenesis, osteoinduction, and osteoconduction) 
guaranteeing a regenerative self-potential [13]. As a 
disadvantage to the autogenous bone graft, the need 
for second surgical access in the donor area stands 
out, resulting in longer surgical time, morbidity, and a 
consequent greater resistance of the patient to the 
proposed treatment. In this context, allogeneic, 
xenogenous, and alloplastic bone grafts are presented 
as an alternative for the treatment of bone defects in 
the jaws, since they avoid the need for a second 
surgical access. 
But due to the need for processing to eliminate 
antigenic components, these grafts are only 
osteoconductive with a lower bone formation potential 
compared to autogenous bone grafting. To increase 
the bone formation potential of these grafts, 
combinations have been proposed to obtain better 
regenerative conditions through the preservation of 
volume (osteoconduction) and the induction of 
differentiation of cell migration (osteoinduction) [14]. 
In the past 20 years, platelet concentrates 
have been proposed as regenerative materials in tissue 
regeneration procedures. Among the platelet 
concentrates proposed in the literature, there is PRP 
(platelet-rich plasma) and FRP (fibrin-rich plasma) that 
act as autogenous platelet aggregates with 
osteoinductive properties. These biomaterials, due to 
low morbidity and possible regenerative potential, have 
been indicated for use in combination with other 
biomaterials or even alone. FRP is a second-generation 
concentrate, that is, no anticoagulant is used for its 
acquisition. The blood of the patient, after being 
collected, is subjected to a specific centrifugation 
force, and thus, the figured elements are separated 
according to their density. From this, the part 
corresponding to the erythrocytes is discarded and the 
resulting platelet concentrate is used for the 
regenerative purpose. Leukocytes and platelets 
synthesize and release a variety of cytokines and 
growth factors that act in chemotaxis, angiogenesis, 
differentiation, and cell inhibition [15]. 
Xenografts are bone minerals derived from 
animals or algae and corals. The organic component is 
removed to eliminate the risk of immunogenic 
responses or disease transmission. Animal derivatives 
are the most used in guided bone regeneration (ROG), 
especially the sterile deproteinized bovine medullary 
bone (OBMED), which has been extensively researched 
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and shown to have similarities with human medullary 
bone. OBMED is a great osteoconduction, providing a 
framework favorable to bone formation. Its slow 
reabsorption contributes a lot to the maintenance of 
the graft volume. It has good wettability and a good 
surface contact angle, favoring contact with the blood 
clot. Elevations of the maxillary sinus floor performed 
using only OBMED demonstrate good osteoconductive 
capacity and excellent biological integration, which 
facilitates bone neoformation. A study with OBMED 
used alone or mixed with autogenous bone in several 
percentages in elevation of the maxillary sinus floor 
demonstrated bone formation similar to that of 
autogenous bone after 9 months [16]. 
The xenografts most used in guided bone 
regeneration procedures are the deproteinized bovine 
bone mineral, commercially known as Bio-Oss®, which 
is the most researched product in regenerative 
dentistry worldwide. It is a bone of bovine origin 
processed to produce natural bone mineral without 
organic elements. After thermal and chemical 
treatments, the inorganic phase of the bovine bone 
consists mainly of hydroxyapatite (HA) which retains 
the porous architecture. The excellent osteoconductive 
properties of Bio-Oss® lead to predictable and efficient 
bone regeneration, Bio-Oss® particles become an 
integral part of the newly formed bone structure and 
retain their volume in the long term [5]. Due to its 
great similarity to human bone, Bio Oss® is 
incorporated into the natural process of modeling and 
remodeling. The highly porous structure of Bio Oss® 
offers a lot of space for the formation of blood vessels 
(angiogenesis) and the deposit of newly formed bone 
(osteogenesis) [5]. 
The surface microstructure of Bio Oss® assists 
in the excellent growth of osteoblasts that are 
responsible for bone formation. In this way, the Bio 
Oss® particles become an integral part of the 
structure of the new bone in the formation and the low 
conversion rate into Bio Oss®'s own (remodeled) 
bone, stabilizes the structure and allows the graft 
volume to be maintained long-term. These 
biofunctional processes make Bio Oss® unique [17]. 
For the success of dental implant practice, 
osseointegration is essential. However, it is a complex 
process with many factors interfering with the 
formation and maintenance of bone tissue around the 
implant, such as topography and surface roughness, 
biocompatibility, and loading conditions. Also, it is 
necessary to have a bone layer of the host that is 
healthy, compatible and that allows primary stability 
[1]. 
Dental implants are being used more and more 
due to the high success rates. However, a large 
portion of the patients do not have sufficient minimum 
bone conditions for the installation of the implants, 
therefore, previous reconstructive bone surgery is 
necessary. It is essential that the dental surgeon 
master the knowledge in the healing process of the 
post-extraction alveoli, to provide correct planning of 
the cases [18]. 
In this sense, after an extraction, the repair 
process occurs in the internal region of the socket 
together with the formation of a clot rich in cells and 
growth factors, promoting neoformation, bone 
remodeling, and soft tissue epithelialization [19-21]. 
During this process, the alveolar ridge undergoes 
relevant changes, both in height and in thickness, 
which influence the possibility of installing the implants 
[22,23]. Thus, the optimized processes of implantology 
and biomaterials allow the installation of implants in 
areas of thin thickness, width, and bone height, with 
the performance of simpler surgeries and with a higher 
rate of success and comfort for the patient [24,25]. 
The lack of bone in the alveolar ridges has 
been a major problem in functional aesthetic recovery 
in patients who have suffered dentoalveolar trauma, 
traumatic tooth extractions, congenital tooth absence, 
maxillary and mandibular pathologies. To fill large 
bone defects, the development of bone regeneration 
improves epithelial barriers for a bone graft, favoring 
greater predictability in alveolar and peri-implant 
reconstructions and has a good prognosis [26]. In this 
sense, the filling biomaterials can be fibrin-rich plasma 
(FRP), Bio-Oss®, hydroxyapatite, lyophilized and 
ground demineralized bone marrow, autogenous bone, 
which is considered the gold standard, among others 
[1]. 
Thus, fibrin-rich plasma (FRP) as an 
autologous biomaterial for use in oral and maxillofacial 
surgery presents most leukocytes, platelets, and 
growth factors, forming a fibrin matrix, with a three-
dimensional architecture [27,28]. The Bio-Oss® 
biomaterial (Geistlich), as it is biodegradable, 
biocompatible, non-toxic, and has low immunogenicity 
and bio stimulators can act in the regeneration of bone 
tissue, since it establishes with the adenomatous 
mesenchymal stem cells the appropriate biological 
niche for bone growth and, thus, allowing the dental 
implant to be as effective as possible [1]. 
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Based on this, two important studies reported 
results on the combined use of Bio-Oss® and FRP. 
Thus, the first study investigated clinically and 
histologically the potential of FRP as grafting material 
in pre-implant reconstructive surgery for severe 
maxillary atrophy after breast elevation procedures in 
106-120-180 days, to determine whether the use of 
FRP can accelerate the bone regeneration process, 
which is essential to promote the stability of the 
implant. This study also includes a control group, in 
which only deproteinized bovine bone (Bio-Oss®) was 
used as a reconstructive material. As a result, the use 
of FRP has optimized bone formation [29]. 
The second study compared the use of Bio-
Oss® mixed with FRP and Bio-Oss® with Tisseel® to 
improve bone regeneration. After elevating the sinus 
membrane in both maxillary sinus cavities, an implant 
was placed in the sinus cavity. In one of the sinus 
cavities, the FRP/Bio-Oss® composite was grafted and 
the Tisseel®/Bio-Oss® composite was grafted into the 
other sinus cavity. After a healing period of 6 months, 
bone formation at the graft sites and bone-implant 
contact were assessed. The average rate of 
osseointegration was 43.5 ± 12.4% and the rate of 
new bone formation was 41.8 ± 5.9% at the 
compound sites FRP/Bio-Oss®. In the composite sites, 
Tisseel® / Bio-Oss® was 30.7 ± 7.9% and 31.3 ± 
6.4%. There were statistically significant differences 
between the groups. The findings of this study 
suggested that when FRP is used as an adjunct to Bio-
Oss® particles for bone augmentation in the maxillary 
sinus, bone formation at the graft sites is significantly 
greater than when Tisseel® is used [5]. 
 
Conclusion 
The use of the FRP associated with Bio-Oss® 
seems to illustrate high success rates with minimal 
costs, which may reduce the amount of bone graft 
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